Objective: To quantify drug impurity by the limitation detection of the convolution spectrum system.
目的：利用褶合光谱仪中杂质限量检测功能对药物中杂质进行定量分析。
Therefore, it is essential that the dosage-form manufacturer evaluate each supplier's drug substance impurity profiles.
因此，剂型生产商评估每个供应商原料药的杂质情况是相当重要的。
Quality assessment of starting materials from multiple sources and the impact of starting material impurities on the impurity profile of the drug substance are discussed with illustrative examples.
从多重来源的起始原料的定量分析和起始原料中的相关物质对药物中的相关物质的影响在本文中也通过具体例子进行了讨论。
CONCLUSION the sample pretreatment method established in this experiment is not only of the minimized impurity interference for drug determination, but also of higher drug recovery.
结论这种样品处理方法既消除了杂质对药物测定的干扰，也保证了较高的提取回收率。
The control of the impurity in guarantee the drug, lowering the bad reaction of the drug plays an important role.
药物的杂质控制对于保证药物的效能，降低药物的不良反应起着很关键的作用。
The control of the impurity in guarantee the drug, lowering the bad reaction of the drug plays an important role.
药物的杂质控制对于保证药物的效能，降低药物的不良反应起着很关键的作用。
应用推荐